|
CMFsurrogate
|
Calibrated Model Fusion Approach to Combine Surrogate Markers |
1.1 |
Jan 25, 2026 |
|
OSsurvival
|
Assessing Surrogacy with a Censored Outcome |
1.0 |
Sep 29, 2022 |
|
OptimalSurrogate
|
Model Free Approach to Quantifying Surrogacy |
1.0 |
Sep 27, 2022 |
|
PTERP
|
PTE and RP for Optimally-Transformed Surrogate |
1.0 |
Oct 10, 2022 |
|
Rsurrogate
|
Robust Estimation of the Proportion of Treatment Effect
Explained by Surrogate Marker Information |
3.2 |
Jan 23, 2024 |
|
SBdecomp
|
Estimation of the Proportion of SB Explained by Confounders |
1.2 |
Nov 15, 2021 |
|
SurrogateOutcome
|
Estimation of the Proportion of Treatment Effect Explained by
Surrogate Outcome Information |
1.2 |
Nov 7, 2025 |
|
SurrogateParadoxTest
|
Empirical Testing of Surrogate Paradox Assumptions |
2.2 |
Apr 12, 2026 |
|
SurrogateRank
|
Rank-Based Test to Evaluate a Surrogate Marker |
3.0 |
Jun 18, 2026 |
|
SurrogateSeq
|
Group Sequential Testing of a Treatment Effect Using a Surrogate
Marker |
1.1 |
Jan 7, 2026 |
|
SurrogateTest
|
Early Testing for a Treatment Effect using Surrogate Marker
Information |
1.3 |
Nov 16, 2021 |
|
cohetsurr
|
Assessing Complex Heterogeneity in Surrogacy |
2.0 |
Apr 10, 2025 |
|
etsi
|
Efficient Testing Using Surrogate Information |
1.0 |
Nov 6, 2025 |
|
hetsurr
|
Assessing Heterogeneity in the Utility of a Surrogate Marker |
1.0 |
Nov 10, 2021 |
|
hetsurrSurv
|
Assessing Heterogeneity in Surrogacy Using Censored Data |
1.0 |
Aug 28, 2024 |
|
hettest
|
Testing for a Treatment Effect Using a Heterogeneous Surrogate
Marker |
1.0 |
Oct 7, 2022 |
|
landest
|
Landmark Estimation of Survival and Treatment Effect |
1.2 |
Aug 25, 2023 |
|
landmix
|
Landmark Prediction for Mixture Data |
1.0 |
Oct 9, 2022 |
|
landpred
|
Landmark Prediction of a Survival Outcome |
2.0 |
Dec 15, 2025 |
|
longsurr
|
Longitudinal Surrogate Marker Analysis |
1.1 |
Nov 9, 2025 |
|
survivalsurrogate
|
Evaluate a Longitudinal Surrogate with a Censored Outcome |
1.1 |
Jun 5, 2025 |